Journal of Proteome Research · 2005 · 217 citations · 12 references
Life SciencesBiochemistryPharmaceutical AnalysisMass Spectrometric AnalysisProtein BiochemistryProteomicsLabel-free QuantificationMass Spectrometry Data AnalysisMass Spectrometry-based ProteomicsPeptide AnalysisProtein QuantificationQuantitative ProteomicsLabel-free DetectionLabel-free Peptide QuantificationPeptide QuantificationProtein Biomarker QuantificationProtein-level QuantificationRelative Protein QuantificationRelative QuantificationVariance Components Analysis
Pharmaceutical companies and regulatory agencies are broadly pursuing biomarkers as a means to increase the productivity of drug development. Quantifying differential levels of proteins from complex biological samples such as plasma or cerebrospinal fluid is one specific approach being used to identify markers of drug action, efficacy, toxicity, etc. We have developed a comprehensive, fully automated, and label-free approach to relative protein quantification from LC-MS/MS experiments of proteolytic protein digests including: de-noising, mass and charge state estimation, chromatographic alignment, and peptide quantification via integration of extracted ion chromatograms. Results from a variance components study of the entire method indicate that most of the variability is attributable to the LC-MS injection, with a median peptide LC-MS injection coefficient of variation of 8% on a ThermoFinnigan LTQ mass spectrometer. Spiked recovery results suggest a quantifiable range of approximately 32-fold for a sample protein.
12
Use of proteomic patterns in serum to identify ovarian cancer
Emanuel F. Petricoin, Ali M. Ardekani, Ben A. Hitt et al. · The Lancet · 2002 · 3.3K citations
Medicine, Gynecology, Oncology +17
TANDEM: matching proteins with tandem mass spectra
Robertson Craig, Ronald C. Beavis · Bioinformatics · 2004 · 2.6K citations · Full text
Junmin Peng, Joshua E. Elias, Carson C. Thoreen et al. · Journal of Proteome Research · 2002 · 1.7K citations